Sleep apnea diagnostic criteria: Difference between revisions

	Sleep Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Sleep apnea from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Polysomnography
Home Oximetry
CT
MRI
Ultrasound
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Sleep apnea diagnostic criteria On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Sleep apnea diagnostic criteria All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Sleep apnea diagnostic criteria
CDC on Sleep apnea diagnostic criteria
Sleep apnea diagnostic criteria in the news
Blogs on Sleep apnea diagnostic criteria
Directions to Hospitals Treating Sleep apnea
Risk calculators and risk factors for Sleep apnea diagnostic criteria

VisualWikitext

Revision as of 13:19, 12 November 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Jesus Rosario Hernandez, M.D. [2]

Overview

The American Academy of Sleep Medicine published a diagnostic manual guidelines.^[1]^[2]

Diagnosis Criteria

DSM-V Diagnostic Criteria for Central Sleep Apnea^[3]

“

A. Evidence by polysomnography of five or more central apneas per hour of sleep.

AND

B. The disorder is not better explained by another current sleep disorder.

Specify whether:

Idiopathic central sleep apnea: Characterized by repeated episodes of apneas and hypopneas during sleep caused by variability in respiratory effort but without evidence of airway obstruction.

Cheyne-Stokes breathing: A pattern of periodic crescendo-decrescendo variation in tidal volume that results in central apneas and hypopneas at a frequency of at least five events per hour, accompanied by frequent arousal.

Central sleep apnea comorbid with opioid use: The pathogenesis of this subtype is attributed to the effects of opioids on the respiratory rhythm generators in the medulla as well as the differential effects on hypoxic versus hypercapnic respiratory drive.

Specify current severity:

Severity of central sleep apnea is graded according to the frequency of the breathing disturbances as well as the extent of associated oxygen desaturation and sleep fragmentation that occur as a consequence of repetitive respiratory disturbances.

”

References

↑ Berry RB, Budhiraja R, Gottlieb DJ, Gozal D, Iber C, Kapur VK; et al. (2012). "Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine". J Clin Sleep Med. 8 (5): 597–619. doi:10.5664/jcsm.2172. PMC 3459210. PMID 23066376.
↑ Epstein LJ, Kristo D, Strollo PJ, Friedman N, Malhotra A, Patil SP; et al. (2009). "Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults". J Clin Sleep Med. 5 (3): 263–76. PMC 2699173. PMID 19960649.
↑ Diagnostic and statistical manual of mental disorders : DSM-5. Washington, D.C: American Psychiatric Association. 2013. ISBN 0890425558.

Template:WH Template:WS

[pmid23066376-1] Berry RB, Budhiraja R, Gottlieb DJ, Gozal D, Iber C, Kapur VK; et al. (2012). "Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine". J Clin Sleep Med. 8 (5): 597–619. doi:10.5664/jcsm.2172. PMC 3459210. PMID 23066376.

[pmid19960649-2] Epstein LJ, Kristo D, Strollo PJ, Friedman N, Malhotra A, Patil SP; et al. (2009). "Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults". J Clin Sleep Med. 5 (3): 263–76. PMC 2699173. PMID 19960649.

[DSMV-3] Diagnostic and statistical manual of mental disorders : DSM-5. Washington, D.C: American Psychiatric Association. 2013. ISBN 0890425558.

[1]

[2]

[3]

@@ Line 18: / Line 18: @@
 Specify whether:
-* '''Idiopathic central sleep apnea:''' Characterized by repeated episodes of [[apnea]]s and [[hypopnea]]s during sleep caused by variability in respiratory effort but without evidence of airway obstruction.
+* Idiopathic central sleep apnea: Characterized by repeated episodes of [[apnea]]s and [[hypopnea]]s during sleep caused by variability in respiratory effort but without evidence of airway obstruction.
-* '''Cheyne-Stokes breathing:''' A pattern of periodic crescendo-decrescendo variation in tidal volume that results in central apneas and hypopneas at a frequency of at least five events per hour, accompanied by frequent arousal.
+* Cheyne-Stokes breathing: A pattern of periodic crescendo-decrescendo variation in tidal volume that results in central apneas and hypopneas at a frequency of at least five events per hour, accompanied by frequent arousal.
-* '''Central sleep apnea comorbid with opioid use:''' The pathogenesis of this subtype is attributed to the effects of [[opioids]] on the respiratory rhythm generators in the [[medulla]] as well as the differential effects on [[hypoxic]] versus hypercapnic respiratory drive.
+* Central sleep apnea comorbid with opioid use: The pathogenesis of this subtype is attributed to the effects of [[opioids]] on the respiratory rhythm generators in the [[medulla]] as well as the differential effects on [[hypoxic]] versus hypercapnic respiratory drive.
 Specify current severity: